Buck Consultants is not one of the biggest benefit consulting firms, but does a lot of work with mid-size and other employers and routinely gives us insight into what is happening with their health plans, including a recent survey on current medical trends. (Buck Survey) 110 health plans or administrators, with over 100 million covered lives, responded to the survey. The headline numbers for medical trend expectations for 2019 are 7.5% for PPO designs, 7.7% for HMO ones and 7.4% for high deductible plans. Note that all these are before any design changes are made and don’t include prescription drug trend. That drug trend was separately estimated by respondents to be 10% for only health plans, but 5.7% by PBMs. Hmmm, wonder if that difference might be the profit margin for PBMs! Ancillary coverages like dental and vision are projected to have a lower trend. These projected trends are slightly lower than those estimated last year for 2018, but still well above inflation. Factors cited by respondents and Buck include hospital consolidation, utilization increases, cost-shifting from government programs and new technologies. In the case of medications, two strong trends are somewhat offsetting each other. On the one hand, increased use of generics and aggressive utilization management reduces spending; but on the other side, extensive marketing and direct-to-consumer campaigns and expensive new products, especially for cancer treatment, are raising costs. Some of the new costs show up on the medical side, as many of the new drugs are administered intravenously or by injection. While long-term charts reflect a steady decline from trend growth a decade ago, the rate of increase has plateaued for the last few years and remains quite high. The pain continues.
Buck Consultants on Medical Cost Trends
By Kevin RocheNovember 21, 2018Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
CVS has finalized its $10.6 billion buyout of Oak Street health, which operates primary care centers for Medicare members. People may think CVS is a drug store company, but it...
May 4, 2023
Option Care, a large home health care provider is acquiring Amedisys, another large player in that market, for $3.6 billion, as consolidation ramps up across health care, likely meaning higher...
May 4, 2023
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
May 31, 2023
Medical Inflation is Real
A long-running report on the health care costs of a typical family reveals higher growth…
May 31, 2023
The Damage from the Epidemic Response
A great paper summarizes the harms from the epidemic response.
May 30, 2023
Whacko Progressives Really Are Violent Authoritarians
Research for once accords with common sense, extreme progressives are in fact narcissistic, violent authoritarians.